CD5/CD7 CAR-T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD5/CD7 CAR-T cells, covering 2024-11-12 to 2024-11-12. Get the full timeline:
Most recent: Clinical Trial Update: Sequential CAR-T Cells Therapy for CD5/CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD5/CD7-Specific CAR-T Cells [Phase 1, Phase 2]